Jaguar Health, Inc. (JAGX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Jaguar Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.934 Before I turn the call over to management, I'd like to remind you that management may 00:00:02.934 -- 00:00:08.339 make forward-looking statements relating to such matters as continued growth prospects 00:00:08.361 -- 00:00:13.487 for the company, uncertainties regarding market acceptance of products, the impact 00:00:13.487 -- 00:00:19.852 of competitive products and pricing, industry trends, and product initiatives, including 00:00:27.924 -- 00:00:32.220 products in the development stage, which may not achieve scientific objectives or meet 00:00:32.220 -- 00:00:35.104 stringent regulatory requirements. 00:00:35.104 -- 00:00:39.030 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:00:39.030 -- 00:00:43.918 results to differ materially from those contemplated in such forward-looking statements. 00:00:43.918 -- 00:00:47.203 These statements are based on currently available information and management's current 00:00:47.203 -- 00:00:51.449 assumptions, expectations, and projections about future events. 00:00:51.449 -- 00:00:55.335 While management believes its assumptions, expectations, and projections are reasonable 00:00:55.335 -- 00:00:59.400 in view of currently available information, your caution not to place undue reliance 00:00:59.400 -- 00:01:03.683 on these forward-looking statements. The company's actual results may differ materially 00:01:03.683 -- 00:01:08.207 from those discussed during the webcast for a variety of reasons, including those described 00:01:08.207 -- 00:01:12.892 in the forward-looking statements and risk factors sections of the company's Form 10-K 00:01:12.892 -- 00:01:14.693 for the year 2025, 00:01:14.693 -- 00:01:20.578 which was filed with the SEC on April 7, ...